<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35082778</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Fine Mapping Analysis of the MHC Region to Identify Variants Associated With Chinese Vitiligo and SLE and Association Across These Diseases.</ArticleTitle><Pagination><StartPage>758652</StartPage><MedlinePgn>758652</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">758652</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.758652</ELocationID><Abstract><AbstractText>The important role of MHC in the pathogenesis of vitiligo and SLE has been confirmed in various populations. To map the most significant MHC variants associated with the risk of vitiligo and SLE, we conducted fine mapping analysis using 1117 vitiligo cases, 1046 SLE cases and 1693 healthy control subjects in the Han-MHC reference panel and 1000 Genomes Project phase 3. rs113465897 (P=1.03&#xd7;10<sup>-13</sup>, OR=1.64, 95%CI =1.44-1.87) and rs3129898 (P=4.21&#xd7;10<sup>-17</sup>, OR=1.93, 95%CI=1.66-2.25) were identified as being most strongly associated with vitiligo and SLE, respectively. Stepwise conditional analysis revealed additional independent signals at rs3130969(p=1.48&#xd7;10<sup>-7</sup>, OR=0.69, 95%CI=0.60-0.79), HLA-DPB1*03:01 (p=1.07&#xd7;10<sup>-6</sup>, OR=1.94, 95%CI=1.49-2.53) being linked to vitiligo and HLA-DQB1*0301 (P=4.53&#xd7;10<sup>-7</sup>, OR=0.62, 95%CI=0.52-0.75) to SLE. Considering that epidemiological studies have confirmed comorbidities of vitiligo and SLE, we used the GCTA tool to analyse the genetic correlation between these two diseases in the HLA region, the correlation coefficient was 0.79 (P=5.99&#xd7;10<sup>-10</sup>, SE=0.07), confirming their similar genetic backgrounds. Our findings highlight the value of the MHC region in vitiligo and SLE and provide a new perspective for comorbidities among autoimmune diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Cao, Zhang, Wang, Hu, Yong, Li, Ge, Chen, Zhen, Yu, Mao, Li, Fan and Sun.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ruixue</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yirui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yong</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Comprehensive Lab, College of Basic Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Huiyao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhen</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yafen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Yiwen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Wencheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Liangdan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059868">HLA-DP beta-Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C071170">HLA-DPB1 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059866">HLA-DQ beta-Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C069051">HLA-DQB1 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006649">Histocompatibility Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059868" MajorTopicYN="N">HLA-DP beta-Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059866" MajorTopicYN="N">HLA-DQ beta-Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006649" MajorTopicYN="N">Histocompatibility Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014820" MajorTopicYN="N">Vitiligo</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MHC</Keyword><Keyword MajorTopicYN="N">fine mapping</Keyword><Keyword MajorTopicYN="N">imputation</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">vitiligo</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35082778</ArticleId><ArticleId IdType="pmc">PMC8784546</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.758652</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet (2015) 386:74&#x2013;84. doi:&#xa0;10.1016/S0140-6736(14)60763-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60763-7</ArticleId><ArticleId IdType="pubmed">25596811</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter EE, Barr SG, Clarke AE. The Global Burden of SLE: Prevalence, Health Disparities and Socioeconomic Impact. Nat Rev Rheumatol (2016) 12:605&#x2013;20. doi:&#xa0;10.1038/nrrheum.2016.137</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.137</ArticleId><ArticleId IdType="pubmed">27558659</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi CW, Eun SH, Choi KH, Bae JM. Increased Risk of Comorbid Rheumatic Disorders in Vitiligo Patients: A Nationwide Population-Based Study. J&#xa0;Dermatol (2017) 44:909&#x2013;13. doi:&#xa0;10.1111/1346-8138.13846</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.13846</ArticleId><ArticleId IdType="pubmed">28370282</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid Autoimmune Diseases in Patients With Vitiligo: A Cross-Sectional Study. J&#xa0;Am Acad Dermatol (2016) 74:295&#x2013;302. doi:&#xa0;10.1016/j.jaad.2015.08.063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2015.08.063</ArticleId><ArticleId IdType="pubmed">26518171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC, et al. . Comorbidity Profiles in Association With Vitiligo: A Nationwide Population-Based Study in Taiwan. J Eur Acad Dermatol Venereol (2015) 29:1362&#x2013;9. doi:&#xa0;10.1111/jdv.12870</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.12870</ArticleId><ArticleId IdType="pubmed">25510261</ArticleId></ArticleIdList></Reference><Reference><Citation>Spritz RA, Andersen GH. Genetics of Vitiligo. Dermatol Clin (2017) 35:245&#x2013;55. doi:&#xa0;10.1016/j.det.2016.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.det.2016.11.013</ArticleId><ArticleId IdType="pmc">PMC5362127</ArticleId><ArticleId IdType="pubmed">28317533</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan C, Ren YQ, Xiang LH, Sun LD, Xu AE, Gao XH, et al. . Genome-Wide Association Study for Vitiligo Identifies Susceptibility Loci at 6q27 and the MHC. Nat Genet (2010) 42:614&#x2013;8. doi:&#xa0;10.1038/ng.603</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.603</ArticleId><ArticleId IdType="pubmed">20526339</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Hayashi M, Fain PR, Suzuki T, Fukai K, Oiso N, et al. . Major Association of Vitiligo With HLA-A*02:01 in Japanese. Pigment Cell Melanoma Res (2015) 28:360&#x2013;2. doi:&#xa0;10.1111/pcmr.12356</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcmr.12356</ArticleId><ArticleId IdType="pmc">PMC4397141</ArticleId><ArticleId IdType="pubmed">25645285</ArticleId></ArticleIdList></Reference><Reference><Citation>Birlea SA, Ahmad FJ, Uddin RM, Ahmad S, Pal SS, Begum R, et al. . Association of Generalized Vitiligo With MHC Class II Loci in Patients From the Indian Subcontinent. J Invest Dermatol (2013) 133:1369&#x2013;72. doi:&#xa0;10.1038/jid.2012.501</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2012.501</ArticleId><ArticleId IdType="pmc">PMC3626744</ArticleId><ArticleId IdType="pubmed">23303446</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, Rich SS, et al. . Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens. PLoS One (2013) 8:e64683. doi:&#xa0;10.1371/journal.pone.0064683</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064683</ArticleId><ArticleId IdType="pmc">PMC3675122</ArticleId><ArticleId IdType="pubmed">23762245</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Han B, Tsoi LC, Stuart PE, Ellinghaus E, Tejasvi T, et al. . Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and its Clinical Subtypes. Am J Hum Genet (2014) 95:162&#x2013;72. doi:&#xa0;10.1016/j.ajhg.2014.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2014.07.002</ArticleId><ArticleId IdType="pmc">PMC4129407</ArticleId><ArticleId IdType="pubmed">25087609</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Momozawa Y, Ashikawa K, Kanai M, Matsuda K, Kamatani Y, et al. . Construction of a Population-Specific HLA Imputation Reference Panel and its Application to Graves' Disease Risk in Japanese. Nat Genet (2015) 47:798&#x2013;802. doi:&#xa0;10.1038/ng.3310</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3310</ArticleId><ArticleId IdType="pubmed">26029868</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, et al. . Major Histocompatibility Complex Associations of Ankylosing Spondylitis Are Complex and Involve Further Epistasis With ERAP1. Nat Commun (2015) 6:7146. doi:&#xa0;10.1038/ncomms8146</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8146</ArticleId><ArticleId IdType="pmc">PMC4443427</ArticleId><ArticleId IdType="pubmed">25994336</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli G, Hayashi M, Jin Y, Yorgov D, Santorico SA, Holcomb C, et al. . MHC Class II Super-Enhancer Increases Surface Expression of HLA-DR and HLA-DQ and Affects Cytokine Production in Autoimmune Vitiligo. Proc Natl Acad Sci USA (2016) 113:1363&#x2013;8. doi:&#xa0;10.1073/pnas.1523482113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1523482113</ArticleId><ArticleId IdType="pmc">PMC4747741</ArticleId><ArticleId IdType="pubmed">26787888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi M, Jin Y, Yorgov D, Santorico SA, Hagman J, Ferrara TM, et al. . Autoimmune Vitiligo Is Associated With Gain-of-Function by a Transcriptional Regulator That Elevates Expression of HLA-A*02:01 In Vivo. Proc Natl Acad Sci USA (2016) 113:1357&#x2013;62. doi:&#xa0;10.1073/pnas.1525001113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1525001113</ArticleId><ArticleId IdType="pmc">PMC4747738</ArticleId><ArticleId IdType="pubmed">26787886</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Wu J, Zhang X, Wen L, Sun J, Cheng Y, et al. . Fine-Mapping Analysis of the MHC Region for Vitiligo Based on a New Han-MHC Reference Panel. Gene (2018) 648:76&#x2013;81. doi:&#xa0;10.1016/j.gene.2018.01.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.01.053</ArticleId><ArticleId IdType="pubmed">29355683</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Cao H, Zuo X, Zhang T, Zhang X, Liu X, et al. . Deep Sequencing of the MHC Region in the Chinese Population Contributes to Studies of Complex Disease. Nat Genet (2016) 48:740&#x2013;6. doi:&#xa0;10.1038/ng.3576</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3576</ArticleId><ArticleId IdType="pubmed">27213287</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Li Q, Liu R, Shen J, Li M, Zhao M, et al. . Association Analysis of the MHC in Lupus Nephritis. J Am Soc Nephrol (2017) 28:3383&#x2013;94. doi:&#xa0;10.1681/ASN.2016121331</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016121331</ArticleId><ArticleId IdType="pmc">PMC5661284</ArticleId><ArticleId IdType="pubmed">28754791</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu SM, Deshmukh US, Gaskin F. Pathogenesis of Systemic Lupus Erythematosus Revisited 2011: End Organ Resistance to Damage, Autoantibody Initiation and Diversification, and HLA-Dr. J Autoimmun (2011) 37:104&#x2013;12. doi:&#xa0;10.1016/j.jaut.2011.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2011.05.004</ArticleId><ArticleId IdType="pmc">PMC3173577</ArticleId><ArticleId IdType="pubmed">21632208</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang XF, Zhang Z, Hu DY, Xu AE, Zhou HS, Sun LD, et al. . Association Analyses Identify Three Susceptibility Loci for Vitiligo in the Chinese Han Population. J Invest Dermatol (2013) 133:403&#x2013;10. doi:&#xa0;10.1038/jid.2012.320</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2012.320</ArticleId><ArticleId IdType="pubmed">22951725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ta&#xef;eb A, Picardo M. The Definition and Assessment of Vitiligo: A Consensus Report of the Vitiligo European Task Force. Pigment Cell Res (2007) 20:27&#x2013;35. doi:&#xa0;10.1111/j.1600-0749.2006.00355.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0749.2006.00355.x</ArticleId><ArticleId IdType="pubmed">17250545</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, et al. . Genome-Wide Association Study in a Chinese Han Population Identifies Nine New Susceptibility Loci for Systemic Lupus Erythematosus. Nat Genet (2009) 41:1234&#x2013;7. doi:&#xa0;10.1038/ng.472</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.472</ArticleId><ArticleId IdType="pubmed">19838193</ArticleId></ArticleIdList></Reference><Reference><Citation>Browning BL, Browning SR. A Unified Approach to Genotype Imputation and Haplotype-Phase Inference for Large Data Sets of Trios and Unrelated Individuals. Am J Hum Genet (2009) 84:210&#x2013;23. doi:&#xa0;10.1016/j.ajhg.2009.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2009.01.005</ArticleId><ArticleId IdType="pmc">PMC2668004</ArticleId><ArticleId IdType="pubmed">19200528</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Yang J, Goddard ME, Visscher PM, Wray NR. Estimation of Pleiotropy Between Complex Diseases Using Single-Nucleotide Polymorphism-Derived Genomic Relationships and Restricted Maximum Likelihood. Bioinformatics (2012) 28:2540&#x2013;2. doi:&#xa0;10.1093/bioinformatics/bts474</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts474</ArticleId><ArticleId IdType="pmc">PMC3463125</ArticleId><ArticleId IdType="pubmed">22843982</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: A Tool for Genome-Wide Complex Trait Analysis. Am J Hum Genet (2011) 88:76&#x2013;82. doi:&#xa0;10.1016/j.ajhg.2010.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2010.11.011</ArticleId><ArticleId IdType="pmc">PMC3014363</ArticleId><ArticleId IdType="pubmed">21167468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu DY, Ren YQ, Zhu KJ, Lv YM, Cheng H, Zhang Z, et al. . Comparisons of Clinical Features of HLA-DRB1*07 Positive and Negative Vitiligo Patients in Chinese Han Population. J Eur Acad Dermatol Venereol (2011) 25:1299&#x2013;303. doi:&#xa0;10.1111/j.1468-3083.2010.03971.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-3083.2010.03971.x</ArticleId><ArticleId IdType="pubmed">21241376</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Sharma P, Kar HK, Sharma VK, Tembhre MK, Gupta S, et al. . HLA Alleles and Amino-Acid Signatures of the Peptide-Binding Pockets of HLA Molecules in Vitiligo. J Invest Dermatol (2012) 132:124&#x2013;34. doi:&#xa0;10.1038/jid.2011.240</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2011.240</ArticleId><ArticleId IdType="pubmed">21833019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouayad A, Benzekri L, Hamada S, Brick C, Hassam B, Essakalli M. Association of HLA Alleles and Haplotypes With Vitiligo in Moroccan Patients: A Case-Control Study. Arch Dermatol Res (2013) 305:925&#x2013;32. doi:&#xa0;10.1007/s00403-013-1368-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00403-013-1368-z</ArticleId><ArticleId IdType="pubmed">23700241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayran Y, &#xd6;zge Ergen G, &#xd6;zmen F. The Relationship Between non-Segmental Vitiligo, HLA Genotype and Oxidative Stress. Int J Clin Pract (2021) 75:e14024. doi:&#xa0;10.1111/ijcp.14024</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14024</ArticleId><ArticleId IdType="pubmed">33434368</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung SA, Brown EE, Williams AH, Ramos PS, Berthier CC, Bhangale T, et al. . Lupus Nephritis Susceptibility Loci in Women With Systemic Lupus Erythematosus. J Am Soc Nephrol (2014) 25:2859&#x2013;70. doi:&#xa0;10.1681/ASN.2013050446</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013050446</ArticleId><ArticleId IdType="pmc">PMC4243339</ArticleId><ArticleId IdType="pubmed">24925725</ArticleId></ArticleIdList></Reference><Reference><Citation>Buc M, Fazekasov&#xe1; H, Cechov&#xe1; E, Hegyi E, Kolib&#xe1;sov&#xe1; K, Ferenc&#xed;k S. Occurrence Rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 Alleles in Patients Suffering From Vitiligo. Eur J Dermatol (1998) 8:13&#x2013;5. doi: 10.1159/000017954</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000017954</ArticleId><ArticleId IdType="pubmed">9653015</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Yang C, Fei W, Zhang X, Sheng Y, Zheng X, et al. . HLA-DQ&#x3b2;1 Amino Acid Position 87 and DQB1*0301 are Associated With Chinese Han SLE. Mol Genet Genomic Med (2018) 6:541&#x2013;6. doi:&#xa0;10.1002/mgg3.403</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.403</ArticleId><ArticleId IdType="pmc">PMC6081216</ArticleId><ArticleId IdType="pubmed">29676044</ArticleId></ArticleIdList></Reference><Reference><Citation>Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Ohnogi Y, et al. . The Genetic Contribution of HLA-DRB5*01:01 to Systemic Lupus Erythematosus in Thailand. Int J Immunogenet (2013) 40:126&#x2013;30. doi: 10.1111/j.1744-313X.2012.01145.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1744-313X.2012.01145.x</ArticleId><ArticleId IdType="pubmed">22862923</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Alarc&#xf3;n-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. . Genome-Wide Association Scan in Women With Systemic Lupus Erythematosus Identifies Susceptibility Variants in ITGAM, PXK, KIAA1542 and Other Loci. Nat Genet (2008) 40:204&#x2013;10. doi:&#xa0;10.1038/ng.81</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.81</ArticleId><ArticleId IdType="pmc">PMC3712260</ArticleId><ArticleId IdType="pubmed">18204446</ArticleId></ArticleIdList></Reference><Reference><Citation>Molineros JE, Chua KH, Sun C, Lian LH, Motghare P, Kim-Howard X, et al. . Evaluation of SLE Susceptibility Genes in Malaysians. Autoimmune Dis (2014) 2014:305436. doi:&#xa0;10.1155/2014/305436</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/305436</ArticleId><ArticleId IdType="pmc">PMC3948475</ArticleId><ArticleId IdType="pubmed">24696779</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd-Yusuf Y, Phipps ME, Chow SK, Yeap SS. HLA-A*11 and Novel Associations in Malays and Chinese With Systemic Lupus Erythematosus. Immunol Lett (2011) 139:68&#x2013;72. doi: 10.1016/j.imlet.2011.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2011.05.001</ArticleId><ArticleId IdType="pubmed">21658414</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, Taylor KE, Fernando MM, Nititham J, Alarc&#xf3;n-Riquelme ME, Barcellos LF, et al. . Unraveling Multiple MHC Gene Associations With Systemic Lupus Erythematosus: Model Choice Indicates a Role for HLA Alleles and non-HLA Genes in Europeans. Am J Hum Genet (2012) 91:778&#x2013;93. doi:&#xa0;10.1016/j.ajhg.2012.08.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.08.026</ArticleId><ArticleId IdType="pmc">PMC3487133</ArticleId><ArticleId IdType="pubmed">23084292</ArticleId></ArticleIdList></Reference><Reference><Citation>Spritz RA. Shared Genetic Relationships Underlying Generalized Vitiligo and Autoimmune Thyroid Disease. Thyroid (2010) 20:745&#x2013;54. doi:&#xa0;10.1089/thy.2010.1643</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2010.1643</ArticleId><ArticleId IdType="pmc">PMC2935342</ArticleId><ArticleId IdType="pubmed">20578892</ArticleId></ArticleIdList></Reference><Reference><Citation>van Geel N, Speeckaert M, Brochez L, Lambert J, Speeckaert R. Clinical Profile of Generalized Vitiligo Patients With Associated Autoimmune/Autoinflammatory Diseases. J Eur Acad Dermatol Venereol (2014) 28:741&#x2013;6. doi: 10.1111/jdv.12169</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.12169</ArticleId><ArticleId IdType="pubmed">23590677</ArticleId></ArticleIdList></Reference><Reference><Citation>Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T. Generalized Vitiligo and Associated Autoimmune Diseases in Japanese Patients and Their Families. Allergol Int (2011) 60:505&#x2013;8. doi: 10.2332/allergolint.11-OA-0303</Citation><ArticleIdList><ArticleId IdType="doi">10.2332/allergolint.11-OA-0303</ArticleId><ArticleId IdType="pubmed">21778811</ArticleId></ArticleIdList></Reference><Reference><Citation>Poojary SA. Vitiligo and Associated Autoimmune Disorders: A Retrospective Hospital-Based Study in Mumbai, India. Allergol Immunopathol (Madr) (2011) 39:356&#x2013;61. doi: 10.1016/j.aller.2010.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aller.2010.12.007</ArticleId><ArticleId IdType="pubmed">21474231</ArticleId></ArticleIdList></Reference><Reference><Citation>Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of Vitiligo, Associated Autoimmune Diseases and Audiological Abnormalities: Ankara Study of 80 Patients in Turkey. J Eur Acad Dermatol Venereol (2010) 24:1144&#x2013;50. doi: 10.1111/j.1468-3083.2010.03605.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-3083.2010.03605.x</ArticleId><ArticleId IdType="pubmed">20202047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadi A, Wang JF, Uppal P, Penn LA, Elbuluk N. Comorbid Diseases of Vitiligo: A 10-Year Cross-Sectional Retrospective Study of an Urban US Population. J Am Acad Dermatol (2020) 82:628&#x2013;33. doi: 10.1016/j.jaad.2019.07.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2019.07.036</ArticleId><ArticleId IdType="pubmed">31325552</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth VM, Guo Y, Qureshi AA. Comorbidities Associated With Vitiligo: A Ten-Year Retrospective Study. Dermatology (2013) 227:311&#x2013;5. doi: 10.1159/000354607</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000354607</ArticleId><ArticleId IdType="pubmed">24107643</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CW, Huang YC. Vitiligo and Autoantibodies: A Systematic Review and Meta-Analysis. J Dtsch Dermatol Ges (2018) 16:845&#x2013;51. doi: 10.1111/ddg.13574</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ddg.13574</ArticleId><ArticleId IdType="pubmed">29972626</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>